Relationship of Adiponectin to Endogenous GH Pulse Secretion Parameters in Response to Stimulation with a Growth Hormone Releasing Factor

Overview

Journal Growth Horm IGF Res

Publisher Elsevier

Specialty Endocrinology

Date 2011 May 3

PMID 21531600

Citations 1

Authors

H Makimura

T L Stanley

C Y Chen

K L Branch

S K Grinspoon

Affiliations

Soon will be listed here.

Abstract

Objective: Obesity is associated with both reduced growth hormone (GH) and adiponectin. However, the relationship between adiponectin and parameters of endogenous GH secretion remains unknown. The aim of this study was to determine the relationship between total and high molecular weight (HMW) adiponectin and parameters of endogenous pulsatile GH secretion and the effects of tesamorelin, a synthetic GH releasing hormone (GHRH(1-44)), on total and HMW adiponectin.

Design: A 2-week interventional study with tesamorelin was conducted at an academic medical center in 13 men with BMI 20-35 kg/m(2). Overnight frequent blood sampling and measurement of total and HMW adiponectin at baseline and after treatment were performed to assess the effects of augmenting endogenous pulsatile GH secretion.

Results: Total, but not HMW, adiponectin was positively associated with log(10)Peak GH area (r=+0.73; P=0.005), basal GH secretion (r=+0.67; P=0.01), and total GH production (r=+0.57; P=0.04), but was not associated with the number of secretion events (P=0.85). Two-week treatment with tesamorelin increased endogenous GH release and IGF-1, but neither total (change -0.16±0.64; P=0.40), nor HMW (change +0.03±0.70; P=0.87) adiponectin changed significantly with treatment. Sub-analyses in overweight and obese men yielded similar results.

Conclusions: Our study demonstrates a strong relationship between specific parameters of endogenous GH pulsatility and adiponectin. However, short-term augmentation of GH pulsatility over 2-weeks does not change adiponectin. Therefore, the relationship between GH and adiponectin is most likely mediated by specific covariates related to adiposity or other factors.

Citing Articles

Frailty status and altered dynamics of circulating energy metabolism hormones after oral glucose in older women.

Kalyani R, Varadhan R, Weiss C, Fried L, Cappola A J Nutr Health Aging. 2012; 16(8):679-86.

PMID: 23076509 DOI: 10.1007/s12603-012-0066-4.

References

Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J . Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999; 257(1):79-83. DOI: 10.1006/bbrc.1999.0255. View

Psilopanagioti A, Papadaki H, Kranioti E, Alexandrides T, Varakis J . Expression of adiponectin and adiponectin receptors in human pituitary gland and brain. Neuroendocrinology. 2008; 89(1):38-47. DOI: 10.1159/000151396. View

Kanety H, Hemi R, Ginsberg S, Pariente C, Yissachar E, Barhod E . Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity. Eur J Endocrinol. 2009; 161(6):837-44. DOI: 10.1530/EJE-09-0419. View

Bonert V, Elashoff J, Barnett P, Melmed S . Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. J Clin Endocrinol Metab. 2004; 89(7):3397-401. DOI: 10.1210/jc.2003-032213. View

Svensson J, Herlitz H, Lundberg P, Johannsson G . Adiponectin, leptin, and erythrocyte sodium/lithium countertransport activity, but not resistin, are related to glucose metabolism in growth hormone-deficient adults. J Clin Endocrinol Metab. 2005; 90(4):2290-6. DOI: 10.1210/jc.2004-1239. View

Schmid C, Bianda T, Zwimpfer C, Zapf J, Wiesli P . Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels. Growth Horm IGF Res. 2005; 15(4):300-3. DOI: 10.1016/j.ghir.2005.06.012. View

Darendeliler F, Aycan Z, Cetinkaya E, Vidilisan S, Bas F, Bideci A . Effects of growth hormone on growth, insulin resistance and related hormones (ghrelin, leptin and adiponectin) in Turner syndrome. Horm Res. 2007; 68(1):1-7. DOI: 10.1159/000098440. View

Riedel M, Hoeft B, Blum W, von zur Muhlen A, Brabant G . Pulsatile growth hormone secretion in normal-weight and obese men: differential metabolic regulation during energy restriction. Metabolism. 1995; 44(5):605-10. DOI: 10.1016/0026-0495(95)90117-5. View

Fukuda I, Hizuka N, Ishikawa Y, Itoh E, Yasumoto K, Murakami Y . Serum adiponectin levels in adult growth hormone deficiency and acromegaly. Growth Horm IGF Res. 2004; 14(6):449-54. DOI: 10.1016/j.ghir.2004.06.005. View

10.

Willemsen R, Mulder P, van Toorenenbergen A, Hokken-Koelega A . Long-term GH treatment is not associated with disadvantageous changes of inflammatory markers and adipocytokines in children born small for gestational age. Clin Endocrinol (Oxf). 2007; 68(2):198-205. DOI: 10.1111/j.1365-2265.2007.03019.x. View

11.

Festen D, van Toorenenbergen A, Duivenvoorden H, Hokken-Koelega A . Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy. J Clin Endocrinol Metab. 2007; 92(4):1549-54. DOI: 10.1210/jc.2006-2241. View

12.

Johnson M, Pipes L, Veldhuis P, Farhy L, Nass R, Thorner M . AutoDecon: a robust numerical method for the quantification of pulsatile events. Methods Enzymol. 2009; 454:367-404. PMC: 2662594. DOI: 10.1016/S0076-6879(08)03815-9. View

13.

Lanes R, Soros A, Gunczler P, Paoli M, Carrillo E, Villaroel O . Growth hormone deficiency, low levels of adiponectin, and unfavorable plasma lipid and lipoproteins. J Pediatr. 2006; 149(3):324-9. DOI: 10.1016/j.jpeds.2006.05.010. View

14.

Nilsson L, Binart N, Bohlooly-Y M, Bramnert M, Egecioglu E, Kindblom J . Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem Biophys Res Commun. 2005; 331(4):1120-6. DOI: 10.1016/j.bbrc.2005.04.026. View

15.

Oliveira C, Salvatori R, Meneguz-Moreno R, Aguiar-Oliveira M, Pereira R, Valenca E . Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency. J Clin Endocrinol Metab. 2009; 95(2):693-8. PMC: 2840862. DOI: 10.1210/jc.2009-1919. View

16.

Xu A, Wong L, Wang Y, Xu J, Cooper G, Lam K . Chronic treatment with growth hormone stimulates adiponectin gene expression in 3T3-L1 adipocytes. FEBS Lett. 2004; 572(1-3):129-34. DOI: 10.1016/j.febslet.2004.07.020. View

17.

Makimura H, Stanley T, Mun D, Chen C, Wei J, Connelly J . Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity. J Clin Endocrinol Metab. 2009; 94(12):5131-8. PMC: 2795664. DOI: 10.1210/jc.2009-1295. View

18.

Steyn F, Boehme F, Vargas E, Wang K, Parkington H, Rao J . Adiponectin regulate growth hormone secretion via adiponectin receptor mediated Ca(2+) signalling in rat somatotrophs in vitro. J Neuroendocrinol. 2009; 21(8):698-704. DOI: 10.1111/j.1365-2826.2009.01887.x. View

19.

Faraj M, Havel P, Phelis S, Blank D, Sniderman A, Cianflone K . Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003; 88(4):1594-602. DOI: 10.1210/jc.2002-021309. View

20.

Stanley T, Chen C, Branch K, Makimura H, Grinspoon S . Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men. J Clin Endocrinol Metab. 2010; 96(1):150-8. PMC: 3038486. DOI: 10.1210/jc.2010-1587. View